Drugs / tamivarotene
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06983210 | May 2025 → Mar 2027 expected | carcinoma of urethra, renal pelvis/ureter urothelial carcinoma, urinary bladder carcinoma | Nagoya University | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | tamivarotene | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06983210 ↗ |